As cigarette sales drop globally due to health concerns and strict regulations, major tobacco companies are shifting to smoke-free products like vapes, heated tobacco, and nicotine pouches. Discover how the cigarette business is being redefined.
Image Courtesy of thehappyturtlestraw
For over a century, the cigarette industry stood as one of the most profitable and influential sectors in the global economy. However, the traditional tobacco business is now facing an unprecedented transformation. As regulatory pressure, public health awareness, and technological disruption continue to mount, cigarette sales are steadily declining across the globe—prompting major players to reimagine their future.
According to data from the World Health Organization (WHO) and Statista, global cigarette consumption has been falling at a consistent pace, especially in high-income countries. In the United States, smoking rates among adults dropped from 21% in 2005 to 11.5% in 2021. Western Europe, Australia, and parts of Asia such as Japan are experiencing similar downtrends.
Meanwhile, tobacco taxation has sharply increased, making smoking less affordable. In many countries, smoking is banned in public spaces, and packaging regulations have intensified. These trends have not only curbed demand but also tarnished the social image of cigarettes.
Governments are becoming increasingly aggressive in discouraging smoking. Countries like New Zealand had previously introduced legislation to ban tobacco sales to future generations. While not all such laws have persisted, the direction is clear—tobacco-free societies are the long-term goal for many governments.
Health campaigns and education, paired with digital tools such as smoking cessation apps, have also made quitting more accessible than ever. The message is resonating, particularly among younger demographics.
Government Regulations: Many countries are imposing strict rules—like higher taxes, graphic warning labels, plain packaging, and public smoking bans.
Health Awareness: People are more aware of the health risks (cancer, heart disease, etc.), and smoking is becoming socially less acceptable.
Alternatives Rising: E-cigarettes, vaping, heated tobacco products (like IQOS), and nicotine pouches are replacing traditional smoking, especially among younger users.
Legal Pushbacks: Countries like New Zealand had proposed laws banning smoking for future generations (though recently rolled back), and others may follow. Developed Markets (US, Europe, Australia, Japan): Shrinking rapidly. Emerging Markets (Indonesia, India, parts of Africa): Still strong, due to weaker regulation and deep-rooted smoking culture.
Cigarette giants like Philip Morris, BAT, and Japan Tobacco are already shifting toward: Heated tobacco. Vapes and e-cigarettes (like Vuse, Juul, IQOS). Cannabis and wellness segments. Pharma-grade nicotine products. Their message: "We’re going smoke-free" — not quitting nicotine, but changing delivery methods.
Short term (5–10 years): Cigarettes will still be around, especially in developing markets. Long term (10–20+ years): Cigarettes may become a niche product or banned in many regions, replaced by alternatives or phased out due to public health policies.
The cigarette business is in slow decline, not an overnight shutdown. It's evolving into a nicotine business rather than dying entirely. Investors and businesses are pivoting to alternative nicotine delivery systems.
Here are several major global cigarette brands that are experiencing declining sales due to shifting consumer behavior, regulations, and the rise of smoke-free alternatives:
Marlboro (Philip Morris International / Altria)
Still the world’s best-selling cigarette brand, but in long-term decline. Key Market: USA (Altria), Europe & Asia (PMI). Decline Driver: U.S. sales of Marlboro have dropped due to tax hikes, anti-smoking campaigns, and competition from e-cigarettes like Juul (which Altria ironically owns a stake in). PMI’s Response: Pivoting to IQOS, a heated tobacco product branded as a “reduced-risk alternative.”
Camel (Japan Tobacco International / Reynolds)
Key Markets: USA, Europe, Middle East. Decline Driver: Reduced shelf presence, stricter advertising bans, and competition from cheaper brands. JT Strategy: Investing more in Ploom X (heated tobacco) and Logic (vape).
Lucky Strike (British American Tobacco)
Key Markets: Europe, Latin America. Decline Driver: Lower demand among Gen Z and Millennials; retail restrictions in many countries. BAT’s Strategy: Heavy investment into Vuse (vape), glo (heated tobacco), and nicotine pouches.
Winston (Japan Tobacco)
Key Markets: Japan, Russia, Europe. Decline Driver: Declining smoking rates in Japan and tightening EU regulations. JT Strategy: Expanding alternative products and acquisitions in the wellness space.
Pall Mall (British American Tobacco)
Key Markets: USA, Germany, Middle East. Decline Driver: Falls under value brand segment; hit hard by taxation and growing health awareness. BAT’s Strategy: Repositioning under a multi-category nicotine model, reducing dependence on combustibles.
Gudang Garam (Indonesia)
PT Gudang Garam Tbk. Type: Kretek (clove cigarette). Key Markets: Indonesia (main), limited exports to Southeast Asia and Middle East. Decline Driver: Health campaigns and proposed tobacco control reforms in Indonesia. Shifting youth preferences toward vaping and Western-style cigarettes. Economic pressure from rising tobacco excise taxes. Current Response: Exploring diversification (e.g. logistics, energy sector), but slow in adopting alternative nicotine products compared to global peers.
Djarum (Indonesia)
PT Djarum. Type: Kretek (clove cigarette). Key Markets: Indonesia, Philippines, limited export markets. Decline Driver: Similar to Gudang Garam: growing public health regulation and rising tax. Urban youth shifting to vapes or quitting altogether. Current Response: Djarum is indirectly expanding into technology (owns part of Tokopedia and BCA via Djarum Group), but its tobacco business remains traditional.
Mevius (Japan)
Japan Tobacco Inc. (JT). Former Name: Mild Seven. Key Markets: Japan, South Korea, Taiwan, Russia. Decline Driver: Japan's rapid adoption of heated tobacco (IQOS, Ploom X). Market saturation and aging demographic of smokers. Government promoting smoke-free environments. Current Response: Heavy investment in Ploom X (heated tobacco system) and other reduced-risk alternatives.
Despite the global decline, cigarette sales remain resilient in low- and middle-income countries. Indonesia, India, and some African nations continue to see high smoking rates due to less stringent regulations, cultural norms, and the influence of local tobacco giants.
Indonesia, for example, is home to over 70 million smokers and one of the highest male smoking rates in the world. Kretek (clove cigarettes) remain culturally embedded, although pressure for regulatory reform is growing.
Major tobacco companies have publicly acknowledged the decline and are pivoting their business models toward reduced-risk products (RRPs). Philip Morris International (PMI), British American Tobacco (BAT), and Japan Tobacco (JT) have invested billions in: Heated tobacco products (e.g., IQOS). E-cigarettes and vapes (e.g., Vuse, blu). Nicotine pouches. Cannabis and CBD ventures. Pharmaceutical nicotine products
Philip Morris aims to become a “smoke-free company,” targeting a future where cigarettes are obsolete. Its smoke-free products accounted for over 30% of total revenue in 2023.
The declining cigarette business signals risk for traditional tobacco-focused investments but opens opportunity in alternative nicotine markets, wellness products, and biotechnology. Investors are urged to monitor companies' transition strategies closely. Brands that innovate, diversify, and respond to regulatory environments will outperform those stuck in legacy models.
The future of the cigarette business is no longer centered on traditional combustible tobacco. Instead, it is shifting toward a “smoke-free future”, with companies reinventing themselves as nicotine, wellness, and technology companies.
Heated Tobacco Products (HTPs). Examples: IQOS (Philip Morris), glo (BAT), Ploom X (Japan Tobacco). Devices that heat tobacco instead of burning it, reducing harmful chemicals. Regarded by some regulators as reduced-risk; gaining traction in Japan, South Korea, and Europe.
E-Cigarettes & Vaping Devices. Examples: Vuse (BAT), blu (Imperial Brands), NJOY (Altria). Huge growth in Gen Z and millennial markets; flavored variants are popular but also controversial. Challenge: Regulatory backlash (e.g., US FDA bans), concerns over youth addiction.
Oral Nicotine Products. Examples: VELO (BAT), ZYN (Swedish Match/Philip Morris). Nicotine pouches, gum, lozenges. Growth Potential: Discreet use, marketed as smoke- and spit-free; big hit in Europe and the U.S.
Cannabis and CBD Business. Tobacco companies are investing in the legal cannabis industry. Altria invested in Canadian cannabis company Cronos. BAT partnered with OrganiGram to explore cannabis products. A natural diversification into another “inhalable” market with high growth.
Wellness and Pharma-Grade Nicotine. Smoking cessation products, therapeutic nicotine, mental wellness. Philip Morris acquired Vectura (a pharmaceutical inhaler company). Potential: Repurposing nicotine for cognitive enhancement or stress relief.
Alternative Investments (Diversification). Strategy: Companies are investing in logistics, fintech, tech startups, and agriculture. Examples: Djarum Group owns BCA (Indonesia’s largest private bank) and Tokopedia. Gudang Garam invested in Kediri Airport project and toll roads.
The future of the cigarette business isn’t about smoking — it’s about nicotine innovation, wellness, and strategic diversification. Cigarette companies are becoming multi-category businesses, with heavy investment in research, biotech, and regulated markets. Traditional smoking may one day vanish, but the business of nicotine consumption and lifestyle adaptation is evolving.
The cigarette industry is not vanishing overnight, but it is evolving fast. While demand may linger in parts of the world, the overall trajectory points downward. The future of nicotine consumption is likely to be smoke-free, tech-driven, and shaped by public health priorities.
For entrepreneurs, policymakers, and investors, understanding this shift is essential to navigating the new tobacco economy.
